Clinical Trials Browser

Phase 2 × Myeloproliferative Disorders × peginterferon alfa-2a × Clear all

NCT00452023 2024-12-11

Pegasys® in Patients With Myeloproliferative Diseases

Phase 2 Completed

83 enrolled 12 charts

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential

NCT00241241 2015-10-21

Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera

Phase 2 Completed

Myeloproliferative Disorders, Polycythemia Vera